Search location filters

Please select a valid location from the dropdown
Clear All
Advanced search
Advanced Filters

Found 142 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Testing a tool for managing children's allergy symptoms.

100 years or below
All genders
This research study is for people who are at least 18 years old. The study is looking at an investigational medication for a certain medical condition. The purpose is to see how safe and effective this medication is for patients. Participants will need to visit the study clinic around 5 …
about the study

Testing a new allergy control method for kids.

100 years or below
All genders
We are conducting a research study to understand how safe and effective an investigational medication is for treating a certain condition. This study is looking for participants who are aged 18 years and older. The study will last for about 6 months, and participants will need to visit the study …
ELIGIBILITY

Testing a new allergic rhinitis control method for kids.

99 years or below
All genders
We are looking for participants to join a research study about an investigational medication for a condition called AAA12. AAA12 involves changes in blood vessels, which could lead to heart problems. The study will help us learn more about how this investigational medication affects AAA12. To join, you must be …
ELIGIBILITY

Allergic Rhinitis Control Test study for children.

100 years or below
All genders
Study Overview: This research is for people who may be interested in participating in a clinical trial involving an investigational medication or vaccine. The purpose of this study is to test the effects and safety of this investigational medication or vaccine in individuals. Eligibility: The study has specific criteria that …
ELIGIBILITY

Study on Iron Levels in Pregnant Women with Twins or Triplets

19 years - 45 years
Accepts healthy volunteer
Female
Phase 1
This study investigates iron levels in pregnant women who are expecting twins or triplets. Iron is important for making red blood cells, which carry oxygen in the body. Pregnant women need more iron, and not having enough can cause problems for both the mother and the babies. The study will …
about the study

Clinical Trial Overview

100 years or below
All genders
This clinical trial aims to evaluate the effectiveness of a new treatment for a specific condition. Participants will be monitored for changes in their health status over the course of the study. The trial is designed to ensure participant safety and gather comprehensive data on the treatment's impact. Who Can …
ELIGIBILITY

Understanding the Clinical Trial Process

100 years or below
All genders
This clinical trial aims to evaluate the effectiveness of a new treatment for managing chronic pain. Participants will receive either the new treatment or a placebo to compare outcomes. The study seeks to improve quality of life for individuals suffering from chronic pain by identifying more effective treatment options. Who …
about the study

Understanding a New Health Study

100 years or below
All genders
This study aims to explore a new approach to improving health outcomes. Participants will be involved in various activities designed to assess the effectiveness of this approach. The study is open to individuals who meet specific criteria and are interested in contributing to medical research. Who Can Participate: Individuals who …
ELIGIBILITY

Validation of COMPAT-SF Spanish Translation

18 years or above
All genders
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
about the study

Prophylactic Peptide Vaccine in Advanced ALK+ NSCLC

18 years or above
All genders
Phase 1/2
The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.
about the study
81 - 90 of 142